🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Kentucky › Louisville

Etid klinik pou Kansè renn (Kasinom selil renn) nan Louisville, KY

5 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Louisville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Ap rekriteFaz 1
  • Research Site, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05536141

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Norton Cancer Institute PARENT, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06750185

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • Baptist Health Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 1
  • Xencor Investigative Site, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Norton Cancer Institute, Louisville
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Louisville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.